New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017

• Cécile Ollivier,
• Haihao Sun,
• Wayne Amchin,
• Maurice Beghetti,
• Rolf M. F. Berger,
• Stefanie Breitenstein,
• Christine Garnett,
• Ninna Gullberg,
• Patrik Hassel,
• Dunbar Ivy,
• Steven M. Kawut,
• Agnes Klein,
• Catherine Lesage,
• Marek Migdal,
• Barbara Nije,
• Michal Odermarsky,
• James Strait,
• Pieter A. de Graeff,
• Norman Stockbridge

Affiliations

Cécile Ollivier

European Medicines Agency London United Kingdom

Haihao Sun

Food and Drug Administration Silver Spring MD

Wayne Amchin

Food and Drug Administration Silver Spring MD

Maurice Beghetti

Pediatric Cardiology Unit Centre Universitaire de Cardiologie et Chirurgie Cardiaque Pédiatrique University Hospitals of Geneva City of Geneva Switzerland

Rolf M. F. Berger

Center for Congenital Heart Diseases Department of Pediatric Cardiology Beatrix Children's Hospital University Medical Center Groningen University of Groningen the Netherlands

Stefanie Breitenstein

Bayer AG, Pharmaceuticals, Research and Development Wuppertal Germany

Christine Garnett

Food and Drug Administration Silver Spring MD

Ninna Gullberg

European Medicines Agency London United Kingdom

Patrik Hassel

PH Sweden Göteborg Sweden

Dunbar Ivy

Heart Institute Children's Hospital Colorado University of Colorado School of Medicine Aurora CO

Steven M. Kawut

Perelman School of Medicine University of Pennsylvania Philadelphia PA

Agnes Klein

Health Canada Ottawa Ontario Canada

Catherine Lesage

Actelion Pharmaceuticals Ltd Allscwil Switzerland

Marek Migdal

Childrens Memorial Health Institute Warsaw Poland

Barbara Nije

Health Canada Ottawa Ontario Canada

Michal Odermarsky

Department of Paediatric Cardiology Paediatric Heart Center Lund University and Skåne University Hospital Lund Sweden

James Strait

MSD Lucerne Switzerland

Pieter A. de Graeff

Medicines Evaluation Board Utrecht the Netherlands

Norman Stockbridge

Food and Drug Administration Silver Spring MD